RE:RE:RE:RE:RE:RE:RE:RE:RE:ONCY January 2024 slide deck - over 120 panc pts studiedWell, don't add me to the list, but could a lot of the recent decline be attributed to leaks that informed the bad guys ONC was going it alone? ANson must have been undoubtedly in the know. Can we assume Roche is not interested in partnering and/or a buyout, at this time. Or, is it a concerted effort on the part of Roche and ONC to let the CRO run this P3 clinical trial at less expense i.e. hiring more personnel etc.